Cargando…
G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
G protein-coupled receptor kinase 2 (GRK2), an important subtype of GRKs, specifically phosphorylates agonist-activated G protein-coupled receptors (GPCRs). Besides, current research confirms that it participates in multiple regulation of diverse cells via a non-phosphorylated pathway, including int...
Autores principales: | Li, Nan, Shan, Shan, Li, Xiu-Qin, Chen, Ting-Ting, Qi, Meng, Zhang, Sheng-Nan, Wang, Zi-Ying, Zhang, Ling-Ling, Wei, Wei, Sun, Wu-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801426/ https://www.ncbi.nlm.nih.gov/pubmed/35111168 http://dx.doi.org/10.3389/fimmu.2021.822345 |
Ejemplares similares
-
CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response
por: Li, Nan, et al.
Publicado: (2022) -
Inflammasome as an Effective Platform for Fibrosis Therapy
por: Chen, Ting-Ting, et al.
Publicado: (2021) -
T Cells in Fibrosis and Fibrotic Diseases
por: Zhang, Mengjuan, et al.
Publicado: (2020) -
Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases
por: Zhu, Jianshu, et al.
Publicado: (2023) -
The association between genetic variants at 3’-UTR and 5’-URR of HLA-G gene and the clinical outcomes of patients with leukemia receiving hematopoietic stem cell transplantation
por: Chen, Ding-Ping, et al.
Publicado: (2023)